These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9386228)

  • 21. The treatment of obesity. A call for prudence and professionalism.
    Kushner R
    Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
    [No Abstract]   [Full Text] [Related]  

  • 22. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CB1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders.
    Antel J; Gregory PC; Nordheim U
    J Med Chem; 2006 Jul; 49(14):4008-16. PubMed ID: 16821760
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluoxetine (Prozac) and other drugs for treatment of obesity.
    Med Lett Drugs Ther; 1994 Nov; 36(936):107-8. PubMed ID: 7968782
    [No Abstract]   [Full Text] [Related]  

  • 25. New developments in the pharmacologic treatment of obesity.
    Fantasia HC
    Nurs Womens Health; 2013; 17(1):53-62. PubMed ID: 23399013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rimonabant, obesity and diabetes.
    Prescrire Int; 2007 Jun; 16(89):122. PubMed ID: 17585427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In brief: Phentermine (Lomaira) for weight loss.
    Med Lett Drugs Ther; 2016 Dec; 58(1509):158. PubMed ID: 27906152
    [No Abstract]   [Full Text] [Related]  

  • 30. The relationship between health-related quality of life and weight loss.
    Kolotkin RL; Crosby RD; Williams GR; Hartley GG; Nicol S
    Obes Res; 2001 Sep; 9(9):564-71. PubMed ID: 11557837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.
    Jordan J; Schlaich M; Redon J; Narkiewicz K; Luft FC; Grassi G; Dixon J; Lambert G; Engeli S; ;
    J Hypertens; 2011 Feb; 29(2):189-93. PubMed ID: 21178784
    [No Abstract]   [Full Text] [Related]  

  • 32. Orlistat. No hurry...
    Can Fam Physician; 1999 Oct; 45():2331-3, 2336-8, 2343-5 passim. PubMed ID: 10540693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonincretin drugs in later-stage development.
    Zimmerman MP; Mehr SR
    Am J Manag Care; 2014 Jan; 20(1 Spec No.):E2. PubMed ID: 25618226
    [No Abstract]   [Full Text] [Related]  

  • 34. [Research and experience with fenfluramine in obesity].
    Pawan GS
    Vie Med Can Fr; 1973 May; 2(5):415-22. PubMed ID: 4732200
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug therapy for obesity.
    Dickerson LM; Carek PJ
    Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].
    J Pharm Belg; 2009 Jun; (2):67-8. PubMed ID: 19739531
    [No Abstract]   [Full Text] [Related]  

  • 37. [No progress without the physician in therapy of obesity].
    Schmidt H; Plauth M
    MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
    Langlois KJ; Forbes JA; Bell GW; Grant GF
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging pharmacological approaches to the treatment of obesity.
    Wasan KM; Looije NA
    J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.